Modified influenza M1 58-66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge.

Autor: Lanfermeijer J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., van de Ven K; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., van Dijken H; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Hendriks M; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Talavera Ormeño CMP; Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands., de Heij F; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Roholl P; Microscope Consultancy, Weesp, Netherlands., Borghans JAM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., van Baarle D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Virology & Immunology Research. Dept Medical Microbiology and Infection prevention, University Medical Center Groningen, Groningen, the Netherlands., de Jonge J; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Jorgen.de.jonge@rivm.nl.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Aug 12; Vol. 8 (1), pp. 116. Date of Electronic Publication: 2023 Aug 12.

Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.

Autor: de Koff EM; Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, Netherlands., van Houten MA; Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands; Department of Paediatrics, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands., de Heij F; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Berbers GAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Bogaert D; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Medical Research Council and University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK. Electronic address: d.bogaert@ed.ac.uk., Sanders EAM; Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.

Publikováno v: Vaccine [Vaccine] 2022 Jan 24; Vol. 40 (3), pp. 408-413. Date of Electronic Publication: 2021 Dec 24.

H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets.

Autor: de Jonge J; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., van Dijken H; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., de Heij F; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Spijkers S; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; Present Address: Lava Therapeutics B.V., Utrecht, the Netherlands., Mouthaan J; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.; 10Present Address: Genmab, Utrecht, the Netherlands., de Jong R; 2Central Veterinary Institute of Wageningen UR, Lelystad, the Netherlands., Roholl P; Microscope Consultancy, Weesp, the Netherlands., Adami EA; 4Influenza Vaccine Plant, Instituto Butantan, São Paulo, Brazil., Akamatsu MA; 5Seção de Vacinas Aeróbicas, Instituto Butantan, São Paulo, Brazil., Ho PL; 5Seção de Vacinas Aeróbicas, Instituto Butantan, São Paulo, Brazil., Brunner L; 6Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Collin N; 6Vaccine Formulation Laboratory, University of Lausanne, Epalinges, Switzerland., Friede M; 7Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland., Ferreira JA; 8Department of Statistics, Informatics and Modelling, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., Luytjes W; 1Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2020 May 11; Vol. 5 (1), pp. 38. Date of Electronic Publication: 2020 May 11 (Print Publication: 2020).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Sequential Immunizations with Influenza Neuraminidase Protein Followed by Peptide Nanoclusters Induce Heterologous Protection.

Autor: Song, Wen-Wen¹ (AUTHOR) songwwen@outlook.com, Wan, Mu-Yang¹ (AUTHOR) wanmuyang@hnu.edu.cn, She, Jia-Yue¹ (AUTHOR) shejiayue@hnu.edu.cn, Zhao, Shi-Long¹ (AUTHOR) slzhao@hnu.edu.cn, Liu, De-Jian¹ (AUTHOR) dejianliu@hnu.edu.cn, Chang, Hai-Yan² (AUTHOR) changhaiyan@hunnu.edu.cn, Deng, Lei^1,3 (AUTHOR) changhaiyan@hunnu.edu.cn

Publikováno v: Viruses (1999-4915). Jan2024, Vol. 16 Issue 1, p77. 12p.